Serenex

Durham, NC

CEO: Richard Kent

Ticker: NYSE: PFE

http://www.pfizer.com

Serenex was an oncology-focused drug development company using its novel chemoproteomics technology to accelerate the discovery of high value therapeutics for important human diseases. Serenex was acquired by Pfizer in April 2008.